BMS at EULAR 2021 Congress
Intended for U.S. scientific audiences only.
he European Congress of Rheumatology 2021 (EULAR 2021 Congress) is an important opportunity to review and share the latest breakthroughs and research for patients living with immune-mediated rheumatic diseases.
Our Data at the European Congress of Rheumatology
Read more about our key data being presented at the meeting.
Our diverse, promising portfolio and pipeline is driven by our focus on offering innovative medicines that transform patients’ lives. Read about how our scientists are addressing some of the most challenging diseases of our time and advancing research across numerous immune-mediated diseases.
Shalabh Singhal, executive director, development program lead, Rheumatology, explains how by targeting the tyrosine kinase 2 (TYK2) pathway, researchers can further our understanding of how to improve care for psoriatic disease.
Our research in immunology and rheumatology spans a number of diseases and pathways. Learn more below.